Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population - Concepedia

Concepedia

Publication | Open Access

Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population

DOI Full Paper Access

19

Citations

25

References

2013

Year

Wei Hong, Kai Wang, Yiping Zhang, Junyan Kou, Dan Hong, Dan Su, Weimin Mao, Xinmin Yu, Fajun Xie, Xiaojian Wang

Journal of Zhejiang University SCIENCE B

Abstract

Our data suggest the value of MTHFR C677T polymorphism as a possible predictive marker of response and TTP in advanced NSCLC patients treated with gemcitabine/platinum.

References

	Year	Citations

Page 1